Withdrawal-Emergent Dyskinesias following Varenicline Therapy
Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literat...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Open
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475689/ |